Shree Ganesh Remedies made a winning bid of Rs 26 crore for Jaiswal Pharmachem's 20,100 sq. m. plot in Ankleshwar, Gujarat.
The company is declared as the highest bidder with Rs 26 crore bid, for the e-auction of assets of Jaiswal Pharmachem, i.e., Plot No 6002 and 6003, GIDC Estate, Ankleshwar (land area approx. 20,100 sq. m.) (Gujarat).
The net profit of Shree Ganesh Remedies surged 51.62% to Rs 4.20 crore in the quarter ended December 2021 as against Rs 2.77 crore during the previous quarter ended December 2020. Net sales jumped 59.35% to Rs 21.13 crore in the quarter ended December 2021 as against Rs 13.26 crore during the previous quarter ended December 2020.
Shares of Shree Ganesh Remedies rose 1.28% to close at Rs 281.75 on BSE on Friday, 11 March 2022.
Shree Ganesh Remedies is an Indian pharmaceuticals company. Its core activities consist of manufacturing & export of pharmaceutical intermediates & fine chemicals and research & development.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU